Can-Fite Biopharma (CANF) Q4 2024 Earnings

29NovConfirmed
Q1 2023
Q2 2024
Q3 2024
Q4 2024
-0.19
-0.13
-0.06
0

Details

Expected EPS
-0.000899
Actual EPS
-0.000899
Surprise EPS
0
Surprise Percent
+0%

Description

Can-Fite Biopharma (CANF) has reported earnings of -0.000899 per share for Q4 2024.

0 Comments

Share your thoughts